Leina Ma

3.4k total citations · 1 hit paper
50 papers, 2.2k citations indexed

About

Leina Ma is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Leina Ma has authored 50 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 21 papers in Cancer Research and 12 papers in Oncology. Recurrent topics in Leina Ma's work include Cancer, Hypoxia, and Metabolism (9 papers), MicroRNA in disease regulation (7 papers) and Ubiquitin and proteasome pathways (7 papers). Leina Ma is often cited by papers focused on Cancer, Hypoxia, and Metabolism (9 papers), MicroRNA in disease regulation (7 papers) and Ubiquitin and proteasome pathways (7 papers). Leina Ma collaborates with scholars based in China, United States and France. Leina Ma's co-authors include Cheng Qian, Zhi Yang, Junjie Shen, Jia Liu, Juanjuan Shan, Yanmin Xu, You‐Hong Cui, Xiu‐Wu Bian, Wenyi Wei and X Y Feng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

Leina Ma

47 papers receiving 2.2k citations

Hit Papers

Light-induced control of protein destruction by opto-PROTAC 2020 2026 2022 2024 2020 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Light-induced control of protein destruction by opto-PROTAC
    2020 226 citations Jing Liu, He Chen et al. Science Advances profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leina Ma China 24 1.6k 793 536 186 164 50 2.2k
Mina Maftouh Iran 26 1.2k 0.7× 752 0.9× 648 1.2× 197 1.1× 189 1.2× 39 1.9k
Vijay Pandey China 30 1.4k 0.9× 706 0.9× 658 1.2× 281 1.5× 226 1.4× 105 2.5k
Chunping Jiang China 27 1.3k 0.8× 850 1.1× 495 0.9× 224 1.2× 157 1.0× 66 2.2k
Xian Lin China 23 1.2k 0.8× 637 0.8× 476 0.9× 166 0.9× 181 1.1× 63 1.7k
Wenchao Liu China 27 1.3k 0.8× 566 0.7× 451 0.8× 327 1.8× 271 1.7× 77 2.1k
Kuo‐Tai Hua Taiwan 30 1.7k 1.0× 716 0.9× 492 0.9× 293 1.6× 179 1.1× 62 2.3k
Jury Gladkich Germany 22 1.0k 0.6× 643 0.8× 724 1.4× 137 0.7× 134 0.8× 32 1.6k

Countries citing papers authored by Leina Ma

Since Specialization
Citations

This map shows the geographic impact of Leina Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leina Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leina Ma more than expected).

Fields of papers citing papers by Leina Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leina Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leina Ma. The network helps show where Leina Ma may publish in the future.

Co-authorship network of co-authors of Leina Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Leina Ma. A scholar is included among the top collaborators of Leina Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leina Ma. Leina Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhao, Gaoxiang, Shudi Luo, Qingxia Ma, et al.. (2025). Nucleus-translocated glucokinase functions as a protein kinase to phosphorylate TAZ and promote tumour growth. Nature Communications. 16(1). 7156–7156.
3.
Zhao, Gaoxiang, Qingxia Ma, Hongfei Jiang, et al.. (2025). CLOCK promotes proliferation of glioblastoma cells through acetylating PRPS1/2. Journal of Neuro-Oncology. 175(2). 657–671.
4.
Chen, Shimin, Yuanyuan Shi, Yuanjing Wang, et al.. (2024). Transcription factor MEF2D regulates aberrant expression of ACSL3 and enhances sorafenib resistance by inhibiting ferroptosis in HCC. Frontiers in Pharmacology. 15. 1464852–1464852. 5 indexed citations
5.
Zhao, Gaoxiang, Qingxia Ma, Yang Huang, et al.. (2023). Base editing of the mutated TERT promoter inhibits liver tumor growth. Hepatology. 79(6). 1310–1323. 8 indexed citations
6.
Chen, Shimin, Jiaojiao Zhao, Qian Lin, et al.. (2023). FBXW7 attenuates tumor drug resistance and enhances the efficacy of immunotherapy. Frontiers in Oncology. 13. 1147239–1147239. 8 indexed citations
7.
Zhao, Jiaojiao, et al.. (2022). Recent Advances of Degradation Technologies Based on PROTAC Mechanism. Biomolecules. 12(9). 1257–1257. 42 indexed citations
8.
Zhao, Jiaojiao, et al.. (2022). CNNArginineMe: A CNN structure for training models for predicting arginine methylation sites based on the One-Hot encoding of peptide sequence. Frontiers in Genetics. 13. 1036862–1036862. 5 indexed citations
9.
Ma, Qingxia, Qianqian Xu, Jiaojiao Zhao, et al.. (2021). Coupling HDAC4 with transcriptional factor MEF2D abrogates SPRY4-mediated suppression of ERK activation and elicits hepatocellular carcinoma drug resistance. Cancer Letters. 520. 243–254. 21 indexed citations
10.
Ma, Qingxia, Hongfei Jiang, Leina Ma, et al.. (2021). Governing glutaminolysis by regulation of glutaminase succinylation. Protein & Cell. 13(3). 163–166. 5 indexed citations
11.
Liu, Jing, He Chen, Leina Ma, et al.. (2020). Light-induced control of protein destruction by opto-PROTAC. Science Advances. 6(8). eaay5154–eaay5154. 226 indexed citations breakdown →
12.
Liu, Jia, et al.. (2020). A narrative review of critical factors for better efficacy of CD19 chimeric antigen receptor T cell therapy in the treatment of B cell malignancies. Translational Cancer Research. 9(9). 5655–5662. 2 indexed citations
13.
Zhang, Lifa, et al.. (2019). Chimeric antigen receptor T cell therapy and other therapeutics for malignancies: Combination and opportunity. International Immunopharmacology. 70. 498–503. 22 indexed citations
14.
Lin, Qian, Leina Ma, Dong Wang, et al.. (2017). A novel Camptothecin analogue inhibits colon cancer development and downregulates the expression of miR-155 in vivo and in vitro. Translational Cancer Research. 6(3). 511–520. 3 indexed citations
15.
Xu, Yanmin, Leina Ma, Juanjuan Shan, et al.. (2015). MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways. Cancer Letters. 371(2). 171–181. 135 indexed citations
16.
Liu, Jia, Leina Ma, Xiao Chen, et al.. (2015). ERK inhibition sensitizes cancer cells to oleanolic acid-induced apoptosis through ERK/Nrf2/ROS pathway. Tumor Biology. 37(6). 8181–8187. 20 indexed citations
17.
Ma, Leina, Jia Liu, Limei Liu, et al.. (2014). Overexpression of the Transcription Factor MEF2D in Hepatocellular Carcinoma Sustains Malignant Character by Suppressing G2–M Transition Genes. Cancer Research. 74(5). 1452–1462. 74 indexed citations
18.
Liu, Jia, et al.. (2013). Tumor‐targeting TRAIL expression mediated by miRNA response elements suppressed growth of uveal melanoma cells. Molecular Oncology. 7(6). 1043–1055. 36 indexed citations
19.
Wang, Bin, Jia Liu, Leina Ma, et al.. (2012). Chimeric 5/35 adenovirus-mediated Dickkopf-1 overexpression suppressed tumorigenicity of CD44+ gastric cancer cells via attenuating Wnt signaling. Journal of Gastroenterology. 48(7). 798–808. 55 indexed citations
20.
Ma, Leina, et al.. (2009). Prognostic value of lymph node metastases and lymph node ratio in esophageal squamous cell carcinoma. European Journal of Surgical Oncology. 36(2). 155–159. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mina Maftouh Breakdown of academic impact, for papers by Vijay Pandey Breakdown of academic impact, for papers by Chunping Jiang Breakdown of academic impact, for papers by Xian Lin Breakdown of academic impact, for papers by Wenchao Liu Breakdown of academic impact, for papers by Kuo‐Tai Hua Breakdown of academic impact, for papers by Jury Gladkich
Rankless by CCL
2026